Compounded GLP-1s Helped Them Lose Weight, But New FDA Rule Could Block Access
A new restriction on the sale of compounded weight loss drugs containing the active ingredient semaglutide is scheduled to take effect in about a month. Eli Lilly and Novo Nordisk are taking steps to help make their brand-name weight loss drugs Zepbound and Wegovy more affordable. Two people who have been taking compounded weight loss…